PNC Financial Services Group
PRME icon

PNC Financial Services Group’s Prime Medicine PRME Stock Holding History

PNC Financial Services Group’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.11K Hold
319
– – ﹤0.01% 4737
2025
Q4 		$1.11K Hold
319
– – ﹤0.01% 4670
2025
Q3 		$1.77K Hold
319
– – ﹤0.01% 4536
2025
Q2 		$788 Sell
319
-5
-2% -$8 ﹤0.01% 4599
2025
Q1 		$645 Buy
324
+178
+122% +$454 ﹤0.01% 4588
2024
Q4 		$426 Buy
146
+118
+421% +$414 ﹤0.01% 4553
2024
Q3 		$108 Sell
28
-86
-75% -$398 ﹤0.01% 4717
2024
Q2 		$586 Buy
+114
New +$691 ﹤0.01% 4509

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

PNC Financial Services Group's PRME Position: Q1 2026 in Review

PNC Financial Services Group held its Prime Medicine (PRME) position steady in Q1 2026 at 319 shares worth $1.11K. The position accounts for ﹤0.01% of the portfolio, ranked #4737.

PNC Financial Services Group first reported a position in PRME in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.77K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • PNC Financial Services Group held 319 shares of Prime Medicine worth $1.11K as of Q1 2026.
  • PNC Financial Services Group left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4737 holding.
  • PNC Financial Services Group first reported a position in Prime Medicine in Q2 2024 and has held it in 8 quarters since.
  • PNC Financial Services Group's Prime Medicine position peaked at $1.77K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.